Liranab
Indication
Liranaftate is a squalene epoxidase inhibitor and cell wall synthesis inhibitor with a chemical structure similar to tolnaftate. It is suitable for the topical treatment of fungal skin infections such as tinea corporis, tinea cruris, tinea cruris, and tinea pedis.
Manufacturer
Kun Shan Rotam Reddy Pharmaceutical Co., Ltd.
-
Founded in:
1993-12-31 -
Address:
No. 2158 Huangpujiang Middle Road, Kunshan Development Zone, Jiangsu Province -
Tax NO.:
91320583608278334C -
Registered Funds:
$25,416,780 -
Website:
-
Email: